NRXN2 (Neurexin-2) variants and mutations
NRXN2 (also known as Neurexin-2) is a human protein-coding gene encoding a neurexin-2 protein. It contributes to presynaptic cell adhesion and synapse organization by binding multiple postsynaptic partners. Rare disruptive variants have been associated with neurodevelopmental and psychiatric phenotypes, although penetrance and gene-disease evidence are less established than for NRXN1. This analysis covers 2,372 NRXN2 variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes gout, osteoarthritis, knee, and mathematical ability. Example NRXN2 variants include A2E, A2T, and S3A.
Variant analysis overview
- Gene: NRXN2
- Protein: Neurexin-2
- UniProt accession: Q9P2S2
- Organism: Homo sapiens
- Variants analyzed: 2372
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 1,810 unspecified-consequence records; 172 synonymous variants; 3 in-frame insertions; 7 in-frame deletions; 336 missense variants; 30 frameshift variants; 12 stop-gained variants; 1 protein altering variant; 1 substitution
- Prediction scores: 1,900 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: gout, osteoarthritis, knee, mathematical ability, Intellectual disability, sleep apnea syndrome, myocardial ischemia, urolithiasis, arthropathy, alcohol drinking, brain compression, edema, epilepsy.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 9 domains; 10 binding sites; 5 post-translational modification sites.
- Structural context: 1,310 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable NRXN2 variants
Examples include A2E, A2T, S3A, G4R, R6L, R6P, W7C, W7G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2E (p.Ala2Glu), TOPMed rs1315309671, gnomAD rs1315309671, REVEL 0.07, MetaLR 0.11
- A2T (p.Ala2Thr), NCI-TCGA TCGA novel, REVEL 0.15, MetaLR 0.11, Variant assessed as somatic; moderate impact.
- S3A (p.Ser3Ala), rs2496350162, ClinGen CA381121881, ClinVar RCV004220593, Uncertain significance, not specified
- G4R (p.Gly4Arg), rs1050157194, ClinGen CA223881905, ClinVar RCV004346527, TOPMed rs1050157194, CADD 17.90, SIFT 0.00, Uncertain significance, not specified
- R6L (p.Arg6Leu), rs922723840, ClinGen CA381121798, ClinVar RCV004282528, 1000Genomes rs922723840, REVEL 0.05, MetaLR 0.09, Uncertain significance, not specified
- R6P (p.Arg6Pro), rs922723840, ClinGen CA223881903, ClinVar RCV004210880, 1000Genomes rs922723840, REVEL 0.07, MetaLR 0.07, Uncertain significance, not specified
- W7C (p.Trp7Cys), gnomAD rs1195602931, REVEL 0.08, MetaLR 0.11
- W7G (p.Trp7Gly), rs977042363, ClinGen CA381121792, ClinVar RCV004220592, REVEL 0.11, MetaLR 0.11, Uncertain significance, not specified
- W7R (p.Trp7Arg), TOPMed rs977042363, gnomAD rs977042363, REVEL 0.07, MetaLR 0.11
- R8L (p.Arg8Leu), TOPMed rs940303150, gnomAD rs940303150, REVEL 0.04, MetaLR 0.10, Uncertain significance
- R8P (p.Arg8Pro), rs940303150, ClinGen CA223881900, ClinVar RCV004186440, TOPMed rs940303150, REVEL 0.10, MetaLR 0.10, Uncertain significance, not specified
- R8Q (p.Arg8Gln), TOPMed rs940303150, gnomAD rs940303150, REVEL 0.03, MetaLR 0.11, Uncertain significance
- R8W (p.Arg8Trp), Ensembl rs2057173945, REVEL 0.12, MetaLR 0.13
- P9L (p.Pro9Leu), rs908791840, ClinGen CA223881898, ClinVar RCV004493654, TOPMed rs908791840, REVEL 0.06, MetaLR 0.10, Likely benign, not specified
- P9S (p.Pro9Ser), gnomAD rs1468924026, REVEL 0.06, MetaLR 0.10
- T10I (p.Thr10Ile), gnomAD rs1376800175, REVEL 0.07, MetaLR 0.08
- P11A (p.Pro11Ala), rs984552176, ClinGen CA223881896, ClinVar RCV004493655, TOPMed rs984552176, CADD 7.86, SIFT 0.58, Uncertain significance, not specified
- P11L (p.Pro11Leu), TOPMed rs2057171687, gnomAD rs2057171687, REVEL 0.11, MetaLR 0.09
- P12T (p.Pro12Thr), gnomAD rs1273507123, REVEL 0.04, MetaLR 0.07
- P13L (p.Pro13Leu), 1000Genomes rs537171549, gnomAD rs537171549, REVEL 0.10, MetaLR 0.07, Uncertain significance, not specified
- L14P (p.Leu14Pro), gnomAD rs1328834551, REVEL 0.15, MetaLR 0.09
- L15M (p.Leu15Met), Ensembl rs1555116495, REVEL 0.06, MetaLR 0.14
- L15P (p.Leu15Pro), TOPMed rs1464900506, gnomAD rs1464900506, REVEL 0.09, MetaLR 0.14
- L16F (p.Leu16Phe), TOPMed rs1023018857, gnomAD rs1023018857, REVEL 0.06, MetaLR 0.16
- L17V (p.Leu17Val), rs797045802, ClinGen CA209262, ClinVar RCV000194830, 1000Genomes rs797045802, REVEL 0.13, MetaLR 0.15, Uncertain significance, not specified
- L18V (p.Leu18Val), TOPMed rs1449966375, gnomAD rs1449966375, REVEL 0.03, MetaLR 0.14
- A21E (p.Ala21Glu), TOPMed rs1215853542, gnomAD rs1215853542, REVEL 0.05, MetaLR 0.08
- A24V (p.Ala24Val), TOPMed rs1372066287, gnomAD rs1372066287, REVEL 0.16, MetaLR 0.25
- R25G (p.Arg25Gly), rs1430815654, ClinGen CA381121405, cosmic curated COSV10720, ClinVar RCV004493662, REVEL 0.10, MetaLR 0.19, Likely benign, not specified
- R25L (p.Arg25Leu), rs1295935415, ClinGen CA381121397, cosmic curated COSV55460, ClinVar RCV004493663, REVEL 0.17, MetaLR 0.18, Uncertain significance, not specified
- R25P (p.Arg25Pro), 1000Genomes rs1295935415, TOPMed rs1295935415, gnomAD rs1295935415, REVEL 0.22, MetaLR 0.22, Uncertain significance
- A26V (p.Ala26Val), TOPMed rs1265312936, REVEL 0.08, AlphaMissense 0.11
- D27E (p.Asp27Glu), TOPMed rs959867285, gnomAD rs959867285, REVEL 0.11, MetaLR 0.18
- D27V (p.Asp27Val), Ensembl rs1460283369
- L29V (p.Leu29Val), TOPMed rs2057165877
- E30A (p.Glu30Ala), rs1242956504, ClinGen CA381121336, ClinVar RCV003488163, 1000Genomes rs1242956504, REVEL 0.42, MetaLR 0.35, Uncertain significance, not provided
- E30D (p.Glu30Asp), TOPMed rs1592312184, gnomAD rs1592312184, REVEL 0.32, MetaLR 0.39
- G32D (p.Gly32Asp), gnomAD rs1354724066, REVEL 0.11, AlphaMissense 0.13
- G33C (p.Gly33Cys), gnomAD rs1169656292, REVEL 0.79, MetaLR 0.69
- G34D (p.Gly34Asp), Ensembl rs2057164268, REVEL 0.25, AlphaMissense 0.10, Uncertain significance, not specified
- G34S (p.Gly34Ser), rs1434434360, TOPMed rs1434434360, gnomAD rs1434434360, REVEL 0.24, AlphaMissense 0.09, Variant assessed as somatic; moderate impact.
- P35R (p.Pro35Arg), rs998690305, ClinGen CA223881885, ClinVar RCV004070007, TOPMed rs998690305, REVEL 0.26, AlphaMissense 0.10, Uncertain significance, not specified
- G36E (p.Gly36Glu), NCI-TCGA TCGA novel, Ensembl rs2057162652, Variant assessed as somatic; moderate impact.
- G36R (p.Gly36Arg), Ensembl rs2057162919, REVEL 0.54, MetaLR 0.59
- Q37* (p.Gln37Ter), NCI-TCGA TCGA novel, CADD 37.00, Variant assessed as somatic; high impact.
- Q37P (p.Gln37Pro), gnomAD rs1245249342, REVEL 0.67, AlphaMissense 0.13
- A39S (p.Ala39Ser), 1000Genomes rs2135676962, REVEL 0.18, MetaLR 0.32
- A39T (p.Ala39Thr), NCI-TCGA TCGA novel, REVEL 0.14, MetaLR 0.23, Variant assessed as somatic; moderate impact.
- R40C (p.Arg40Cys), TOPMed rs903136095, gnomAD rs903136095, REVEL 0.74, AlphaMissense 0.11, Uncertain significance, not specified
- Y41* (p.Tyr41Ter), NCI-TCGA TCGA novel, ExAC rs761811931, TOPMed rs761811931, gnomAD rs761811931, CADD 34.00, Variant assessed as somatic; high impact.
- Y41C (p.Tyr41Cys), gnomAD rs1249976861, REVEL 0.63, MetaLR 0.54
- A42T (p.Ala42Thr), TOPMed rs2057160773, REVEL 0.01, AlphaMissense 0.07
- R43H (p.Arg43His), TOPMed rs2057160541, REVEL 0.18, MetaLR 0.26
- G46R (p.Gly46Arg), ExAC rs768737747, gnomAD rs768737747, CADD 17.10, SIFT 0.03
- G46S (p.Gly46Ser), rs768737747, ExAC rs768737747, gnomAD rs768737747, REVEL 0.15, MetaLR 0.20, Variant assessed as somatic; moderate impact.
- A47S (p.Ala47Ser), gnomAD rs1252751874, CADD 15.40, SIFT 0.05
- A47T (p.Ala47Thr), cosmic curated COSV10961, gnomAD rs1252751874, CADD 15.80, SIFT 0.37
- A48G (p.Ala48Gly), ExAC rs748751882, TOPMed rs748751882, gnomAD rs748751882, REVEL 0.22, MetaLR 0.14, Uncertain significance
- A48V (p.Ala48Val), rs748751882, ClinGen CA6078755, ClinVar RCV004184838, ExAC rs748751882, CADD 19.40, SIFT 0.00, Uncertain significance, not specified
- S49G (p.Ser49Gly), Ensembl rs2135676870, REVEL 0.14, MetaLR 0.26
- S50N (p.Ser50Asn), ExAC rs774928292, gnomAD rs774928292, REVEL 0.14, MetaLR 0.15
- G51D (p.Gly51Asp), ExAC rs745555224, TOPMed rs745555224, gnomAD rs745555224, REVEL 0.52, MetaLR 0.54
- G51S (p.Gly51Ser), gnomAD rs1316250997, REVEL 0.28, MetaLR 0.25
- E52* (p.Glu52Ter), TOPMed rs1011274314, gnomAD rs1011274314, CADD 35.00
- E52G (p.Glu52Gly), Ensembl rs2135676831, REVEL 0.61, MetaLR 0.52
- E52K (p.Glu52Lys), TOPMed rs1011274314, gnomAD rs1011274314, REVEL 0.53, MetaLR 0.48
- L53F (p.Leu53Phe), 1000Genomes rs568060819, ExAC rs568060819, TOPMed rs568060819, gnomAD rs568060819, REVEL 0.63, MetaLR 0.58
- L53I (p.Leu53Ile), 1000Genomes rs568060819, ExAC rs568060819, TOPMed rs568060819, gnomAD rs568060819, REVEL 0.51, MetaLR 0.52
- L53P (p.Leu53Pro), Ensembl rs2135676785, REVEL 0.89, MetaLR 0.69
- S54G (p.Ser54Gly), gnomAD rs1414551444, REVEL 0.63, MetaLR 0.52
- S54I (p.Ser54Ile), 1000Genomes rs1592311400, REVEL 0.72, MetaLR 0.57
- S54N (p.Ser54Asn), 1000Genomes rs1592311400, REVEL 0.33, MetaLR 0.39
- S54R (p.Ser54Arg), 1000Genomes rs1315160787, TOPMed rs1315160787, gnomAD rs1315160787, REVEL 0.77, MetaLR 0.56
- S54T (p.Ser54Thr), 1000Genomes rs1592311400, REVEL 0.47, MetaLR 0.44
- F55L (p.Phe55Leu), ExAC rs748532027, gnomAD rs748532027, REVEL 0.62, MetaLR 0.43
- S56G (p.Ser56Gly), gnomAD rs1157043042, CADD 20.50, SIFT 0.00
- S56I (p.Ser56Ile), ExAC rs755477420, TOPMed rs755477420, gnomAD rs755477420, REVEL 0.24, MetaLR 0.32
- R58H (p.Arg58His), NCI-TCGA Cosmic COSV5546, cosmic curated COSV55464, REVEL 0.67, MetaLR 0.66, Variant assessed as somatic; moderate impact.
- R58L (p.Arg58Leu), ExAC rs753950974, gnomAD rs753950974, REVEL 0.73, MetaLR 0.59
- R58S (p.Arg58Ser), NCI-TCGA TCGA novel, REVEL 0.67, MetaLR 0.56, Variant assessed as somatic; moderate impact.
- T59N (p.Thr59Asn), NCI-TCGA TCGA novel, REVEL 0.84, MetaLR 0.83, Variant assessed as somatic; moderate impact.
- N60D (p.Asn60Asp), Ensembl rs1565482317, REVEL 0.29, MetaLR 0.40
- A61T (p.Ala61Thr), NCI-TCGA TCGA novel, REVEL 0.18, MetaLR 0.30, Variant assessed as somatic; moderate impact.
- R63C (p.Arg63Cys), ExAC rs766431359, gnomAD rs766431359, REVEL 0.68, MetaLR 0.46
- A64G (p.Ala64Gly), rs750652259, ClinGen CA6078743, cosmic curated COSV10584, ClinVar RCV004349237, REVEL 0.11, MetaLR 0.08, Uncertain significance, not specified
- A64V (p.Ala64Val), ExAC rs750652259, TOPMed rs750652259, gnomAD rs750652259, REVEL 0.66, MetaLR 0.57, Uncertain significance
- L65V (p.Leu65Val), ExAC rs767883855, gnomAD rs767883855, REVEL 0.62, MetaLR 0.55
- Y68H (p.Tyr68His), ExAC rs764121263, gnomAD rs764121263, REVEL 0.80, MetaLR 0.65
- L69R (p.Leu69Arg), 1000Genomes rs566365476, REVEL 0.71, MetaLR 0.46
- L69V (p.Leu69Val), Ensembl rs2057149632
- D71H (p.Asp71His), ExAC rs762854242, gnomAD rs762854242, REVEL 0.80, MetaLR 0.68
- G72D (p.Gly72Asp), Ensembl rs1565482048, REVEL 0.29, MetaLR 0.44
- G72S (p.Gly72Ser), TOPMed rs1041650760, gnomAD rs1041650760, REVEL 0.40, MetaLR 0.49
- G73R (p.Gly73Arg), Ensembl rs2057148125
- G73V (p.Gly73Val), cosmic curated COSV55459, gnomAD rs1384890684, REVEL 0.73, MetaLR 0.65
- D74N (p.Asp74Asn), ExAC rs775042347, TOPMed rs775042347, gnomAD rs775042347, REVEL 0.11, MetaLR 0.13
- D74Y (p.Asp74Tyr), ExAC rs775042347, TOPMed rs775042347, gnomAD rs775042347, REVEL 0.16, MetaLR 0.16
- C75G (p.Cys75Gly), ExAC rs769227620, TOPMed rs769227620, gnomAD rs769227620, REVEL 0.63, MetaLR 0.47
- C75R (p.Cys75Arg), ExAC rs769227620, TOPMed rs769227620, gnomAD rs769227620, REVEL 0.70, MetaLR 0.50
- D76N (p.Asp76Asn), Ensembl rs2057146588, REVEL 0.72, MetaLR 0.70
- F77S (p.Phe77Ser), ExAC rs776095862, REVEL 0.78, MetaLR 0.62
- L78P (p.Leu78Pro), gnomAD rs1188023252, REVEL 0.75, MetaLR 0.64
- E79D (p.Glu79Asp), TOPMed rs868408292, REVEL 0.55, MetaLR 0.56
- L80P (p.Leu80Pro), gnomAD rs1465281239, REVEL 0.76, MetaLR 0.77
- L80V (p.Leu80Val), ExAC rs779319497, TOPMed rs779319497, gnomAD rs779319497, REVEL 0.56, MetaLR 0.69
- L81Q (p.Leu81Gln), rs12273892, ClinGen CA154152, cosmic curated COSV10720, ClinVar RCV000117848, REVEL 0.24, MetaLR 0.00, Benign, not provided
- V83L (p.Val83Leu), Ensembl rs2135676247, REVEL 0.08, MetaLR 0.23
- D84E (p.Asp84Glu), ExAC rs780155507, gnomAD rs780155507, REVEL 0.16, MetaLR 0.27
- D84G (p.Asp84Gly), Ensembl rs2135676221, REVEL 0.17, MetaLR 0.25
- D84N (p.Asp84Asn), gnomAD rs1326279397, REVEL 0.20, MetaLR 0.32
- G85D (p.Gly85Asp), gnomAD rs866122162, REVEL 0.77, MetaLR 0.80
- R86H (p.Arg86His), TOPMed rs1459898358, gnomAD rs1459898358, REVEL 0.33, MetaLR 0.33
- R86S (p.Arg86Ser), cosmic curated COSV55458, 1000Genomes rs200558486, ESP rs200558486, ExAC rs200558486, REVEL 0.52, MetaLR 0.41
- R88G (p.Arg88Gly), ExAC rs781507844, gnomAD rs781507844, REVEL 0.47, MetaLR 0.42
- R88W (p.Arg88Trp), ExAC rs781507844, gnomAD rs781507844, REVEL 0.66, MetaLR 0.53
- F91L (p.Phe91Leu), ExAC rs757559993, gnomAD rs757559993, REVEL 0.68, MetaLR 0.51
- T92M (p.Thr92Met), TOPMed rs915873153, gnomAD rs915873153, REVEL 0.35, MetaLR 0.41
- L93F (p.Leu93Phe), TOPMed rs1408459116, gnomAD rs1408459116, REVEL 0.18, MetaLR 0.39
- L93V (p.Leu93Val), TOPMed rs1408459116, gnomAD rs1408459116, REVEL 0.09, MetaLR 0.30
- A96G (p.Ala96Gly), ExAC rs751385058, TOPMed rs751385058, gnomAD rs751385058, REVEL 0.17, MetaLR 0.22, Uncertain significance
- A96V (p.Ala96Val), rs751385058, ClinGen CA6078725, ClinVar RCV004261101, ExAC rs751385058, REVEL 0.64, MetaLR 0.56, Uncertain significance, not specified
- P98A (p.Pro98Ala), cosmic curated COSV55448, TOPMed rs1418733682, gnomAD rs1418733682
- P98S (p.Pro98Ser), TOPMed rs1418733682, gnomAD rs1418733682, REVEL 0.42, MetaLR 0.48
- A99T (p.Ala99Thr), ExAC rs762916724, gnomAD rs762916724, REVEL 0.29, MetaLR 0.37
- T100M (p.Thr100Met), gnomAD rs1267435128, REVEL 0.54, MetaLR 0.55
- T100P (p.Thr100Pro), TOPMed rs2057136476
- L103R (p.Leu103Arg), Ensembl rs2057135717
- T105A (p.Thr105Ala), TOPMed rs1405074266, gnomAD rs1405074266, REVEL 0.27, MetaLR 0.31, Uncertain significance, not specified
- T105K (p.Thr105Lys), TOPMed rs1337021462, gnomAD rs1337021462, REVEL 0.37, MetaLR 0.26
- T105M (p.Thr105Met), TOPMed rs1337021462, gnomAD rs1337021462, REVEL 0.43, MetaLR 0.37, Uncertain significance, not specified
- A108T (p.Ala108Thr), TOPMed rs1250021653, gnomAD rs1250021653, REVEL 0.19, MetaLR 0.19, Uncertain significance, not specified
- D109E (p.Asp109Glu), 1000Genomes rs765238870, ExAC rs765238870, TOPMed rs765238870, gnomAD rs765238870, REVEL 0.66, MetaLR 0.76
- R111C (p.Arg111Cys), TOPMed rs2057133048, gnomAD rs2057133048, REVEL 0.56, MetaLR 0.55
- R111L (p.Arg111Leu), gnomAD rs1343530179, REVEL 0.30, MetaLR 0.26
- H113N (p.His113Asn), TOPMed rs1285641486, REVEL 0.88, MetaLR 0.80
- V115E (p.Val115Glu), Ensembl rs2057132282
- R119C (p.Arg119Cys), gnomAD rs1489784813, REVEL 0.86, MetaLR 0.71
- D120A (p.Asp120Ala), rs1324262269, ClinGen CA381119460, cosmic curated COSV55452, ClinVar RCV000499787, REVEL 0.42, MetaLR 0.36, Conflicting interpretations, not specified
- R122C (p.Arg122Cys), gnomAD rs1394563054, REVEL 0.69, MetaLR 0.59
- R122H (p.Arg122His), NCI-TCGA TCGA novel, REVEL 0.57, MetaLR 0.55, Variant assessed as somatic; moderate impact.
- R122L (p.Arg122Leu), Ensembl rs2057129996, REVEL 0.39, MetaLR 0.35
- R123C (p.Arg123Cys), gnomAD rs2057129444, REVEL 0.48, MetaLR 0.46
- T124M (p.Thr124Met), rs776121419, ClinGen CA6078719, ClinVar RCV004493656, ExAC rs776121419, REVEL 0.77, MetaLR 0.60, Uncertain significance, not specified
- A125V (p.Ala125Val), TOPMed rs1198083943, REVEL 0.15, MetaLR 0.17
- L126M (p.Leu126Met), rs370521049, ClinGen CA6078718, ClinVar RCV000503194, 1000Genomes rs370521049, REVEL 0.69, MetaLR 0.77, Uncertain significance, not specified
- L126Q (p.Leu126Gln), Ensembl rs2135675612
- L126V (p.Leu126Val), rs370521049, ClinGen CA223881825, ClinVar RCV004229494, 1000Genomes rs370521049, REVEL 0.75, MetaLR 0.80, Uncertain significance, not specified
- V128A (p.Val128Ala), TOPMed rs2057127713, gnomAD rs2057127713, REVEL 0.80, MetaLR 0.76
- D129G (p.Asp129Gly), Ensembl rs2057127456, REVEL 0.83, MetaLR 0.79
- G130C (p.Gly130Cys), ExAC rs774679959, TOPMed rs774679959, gnomAD rs774679959, REVEL 0.74, MetaLR 0.64
- G130S (p.Gly130Ser), rs774679959, ExAC rs774679959, TOPMed rs774679959, gnomAD rs774679959, REVEL 0.37, MetaLR 0.50, Variant assessed as somatic; moderate impact.
- E131* (p.Glu131Ter), ExAC rs769052958, TOPMed rs769052958, gnomAD rs769052958, CADD 36.00
- E131K (p.Glu131Lys), ExAC rs769052958, TOPMed rs769052958, gnomAD rs769052958, REVEL 0.49, MetaLR 0.53
- E131V (p.Glu131Val), TOPMed rs2057126332
- A132D (p.Ala132Asp), gnomAD rs2057126096, REVEL 0.15, MetaLR 0.32
- R133C (p.Arg133Cys), gnomAD rs2057125564, REVEL 0.54, MetaLR 0.46
- R133G (p.Arg133Gly), gnomAD rs2057125564, REVEL 0.20, MetaLR 0.21
- R133L (p.Arg133Leu), Ensembl rs2135675508, REVEL 0.20, MetaLR 0.24
- V137G (p.Val137Gly), Ensembl rs2135675478, REVEL 0.70, MetaLR 0.65
- V137L (p.Val137Leu), TOPMed rs1337883189, gnomAD rs1337883189, REVEL 0.35, MetaLR 0.46
- R138S (p.Arg138Ser), gnomAD rs1393547200, REVEL 0.31, MetaLR 0.38
- R141W (p.Arg141Trp), cosmic curated COSV55454, gnomAD rs1207761672, REVEL 0.81, MetaLR 0.61
- E143K (p.Glu143Lys), cosmic curated COSV10584, Ensembl rs1021972151, REVEL 0.30, MetaLR 0.33
- M144I (p.Met144Ile), gnomAD rs1344045371, REVEL 0.71, MetaLR 0.55, Uncertain significance, not specified
- S148G (p.Ser148Gly), 1000Genomes rs2135675432, REVEL 0.63, MetaLR 0.51
- D149N (p.Asp149Asn), ExAC rs780377622, TOPMed rs780377622, gnomAD rs780377622, REVEL 0.55, MetaLR 0.53
- F151L (p.Phe151Leu), rs2057122061, ClinGen CA381118428, ClinVar RCV001251862, Ensembl rs2057122061, REVEL 0.71, MetaLR 0.57, Likely benign, Intellectual disability
- V152A (p.Val152Ala), gnomAD rs1425849678, REVEL 0.81, MetaLR 0.67
- G154C (p.Gly154Cys), gnomAD rs1347724629, REVEL 0.90, MetaLR 0.85
- G154D (p.Gly154Asp), ExAC rs199786530, gnomAD rs199786530, REVEL 0.93, MetaLR 0.85
- G154V (p.Gly154Val), NCI-TCGA TCGA novel, ExAC rs199786530, gnomAD rs199786530, REVEL 0.92, MetaLR 0.85, Variant assessed as somatic; moderate impact.
- P157A (p.Pro157Ala), TOPMed rs1248456352, gnomAD rs1248456352, REVEL 0.28, MetaLR 0.27
- P157H (p.Pro157His), TOPMed rs2057120755, gnomAD rs2057120755, REVEL 0.67, MetaLR 0.54
- P157L (p.Pro157Leu), TOPMed rs2057120755, gnomAD rs2057120755, REVEL 0.50, MetaLR 0.43
- P157S (p.Pro157Ser), TOPMed rs1248456352, gnomAD rs1248456352, REVEL 0.21, MetaLR 0.24
- D158N (p.Asp158Asn), gnomAD rs1238368226, REVEL 0.47, MetaLR 0.51
- V159L (p.Val159Leu), Ensembl rs866194449, REVEL 0.12, MetaLR 0.21
- L161F (p.Leu161Phe), gnomAD rs2057119472, REVEL 0.45, MetaLR 0.52
- S162L (p.Ser162Leu), NCI-TCGA Cosmic COSV5545, REVEL 0.63, MetaLR 0.47, Variant assessed as somatic; moderate impact.
- A163S (p.Ala163Ser), 1000Genomes rs781477164, ExAC rs781477164, TOPMed rs781477164, gnomAD rs781477164, REVEL 0.36, MetaLR 0.42, Uncertain significance, not specified
Public NRXN2 analysis runs
- NRXN2 analysis run — NRXN2 (2,372 variants) — completed 2026-08-19